Department profile
DLA Piper LLP

Life Sciences

Asia-Pacific Guide 2026 : Asia-Pacific Region

Share profile

DLA Piper LLP

About

Provided by DLA Piper LLP



You can learn more about our practice at dlapiper.com.


Chambers Review

Provided by Chambers

Life Sciences - Asia-Pacific Region

Band 1

What the Team is Known For
DLA Piper maintains a sizeable team with a full life sciences offering which includes coverage of anti-corruption, compliance, clinical trials, IP, regulatory and competition law issues. It is particularly respected for its skilled handling of patent litigation, including infringement, amendment, revocation and enforcement for major pharmaceutical companies. The firm is also noted for its experience handling high-value cross-border transactional matters and commercialisation matters. The team acts for a broad range of biotech, healthcare, pharmaceutical and vaccine companies and has impressive geographical coverage, with offices in Australia, New Zealand, China, Japan, South Korea, Singapore and Thailand.
Notable practitioners

Nicholas Tyacke and Sammy Fang are main contacts for the life sciences practice, based in Sydney and Singapore respectively.

View ranking table

Work Highlights

Provided by Chambers

  • DLA Piper acted for Neurim in patent infringement and revocation proceedings in the Federal Court relating to Neurim’s patent that covers its unique prolonged release melatonin product.

Strengths

Provided by Chambers

  • The team at DLA Piper is very hard-working and committed to client service. It leaves no stone unturned and have excellent knowledge of the patent system internationally.

    Life Sciences respondentAsia-Pacific

DLA Piper LLP has rankings in the following guides

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership